Prolongation of corneal allograft survival by CTLA4-FasL in a murine model

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 245, Issue 11, 2007, Pages 1691-1697

  Shi, Weiyun ^a   Chen, Min ^a,b   Xie, Lixin ^a  

^a SHANDONG EYE INSTITUTE   (China)

^b QINGDAO UNIVERSITY   (China)

Author keywords

Corneal transplantation; CTLA4 FasL; Immune rejection; Mice

Indexed keywords

CYCLOSPORIN A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR EYE CHAMBER; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CORNEA TRANSPLANTATION; DRUG DELIVERY SYSTEM; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOHISTOLOGY; IMMUNOLOGICAL TOLERANCE; KERATOPLASTY; LYMPHOCYTE ACTIVATION; MALE; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; SURVIVAL TIME;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CORNEA; CYCLOSPORINE; DISEASE MODELS, ANIMAL; FAS LIGAND PROTEIN; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IN SITU NICK-END LABELING; KERATOPLASTY, PENETRATING; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECOMBINANT FUSION PROTEINS; SKIN TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 34848847201     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-007-0606-5     Document Type: Article

References (32)

1. Larkin DF, Calder VL, Lightman SL (1997) Identification and characterization of cells infiltrating the graft and aqueous humour in rat corneal allograft rejection. Clin Exp Immunol 107:381-391
2. Williams KA, Muehlberg SM, Lewis RF, Coster DJ (1995) How successful is corneal transplantation? A report from the Australian Corneal Graft Register. Eye 9:219-227
3. Brunet JF, Denizot F, Luciani MF, Roux-Dosseto M, Suzan M, Mattei MG, Golstein PA (1987) A new member of the immunoglobulin superfamily-CTLA4. Nature 328:267-270
4. Comer RM, King WJ, Ardjomand N, Theoharis S, George AJ, Larkin DF (2002) Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival. Invest Ophthalmol Vis Sci 43:1095-1103
5. Gebhardt BM, Hodkin M, Varnell ED, Kaufman HE (1999) Protection of corneal allografts by CTLA4-Ig. Cornea 18:314-320
6. Hoffmann F, Zhang EP, Pohl T, Kunzendorf U, Wachtlin J, Bulfone-Paus S (1997) Inhibition of corneal allograft reaction by CTLA4-Ig. Graefes Arch Clin Exp Ophthalmol 235:535-540
7. Smart PM, Grifith TS, Usui N, Pepose J, Yu X, Ferguson TA (1997) CD95 ligand (FasL) induced apoptosis is necessary for corneal allografts survival. J Clin Invest 99:396-402
8. Yamagami S, Kawashima H, Tsuru T (1997) Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants. Transplantation 64:1107-1111
9. Elhalel MD, Huang JH, Schmidt W, Rachmilewitz J, Tykocinski ML (2003) CTLA-4. FasL induces alloantigen-specific hyporesponsiveness. J Immunol 170:5842-5850
10. Huang JH, Tykocinski ML (2001) CTLA-4-Fas ligand functions as a trans signal converter protein in bridging antigen-presenting cells and T cells. Int Immunol 13:529-539
11. Sonoda Y, Streilein JW (1992) Orthotopic corneal transplantation in mice-evidence that the immunogenetic rules of rejection do not apply. Transplantation 54:694-704
12. Joo CK, Pepose JS, Stuart PM (1995) T-cell mediated responses in a murine model of orthotopic corneal transplantation. Invest Ophthalmol Vis Sci 36:1530-1540
13. Sonoda Y, Sano Y, Ksander B, Streilein JW (1995) Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci 36:427-434
14. + T cells in immunobiology of orthotopic corneal transplants in mice. Invest Ophthalmol Vis Sci 40:2614-2621
15. Burke JF Jr, Pirsch JD, Ramos EL, Salomon DR, Stablein DM, van Buren DH, West JC (1994) Long-term efficacy and safety of cyclosporine in renal-transplant recipients. N Engl J Med 331:358-363
16. Simmons RL, Wang SC (1991) New horizons in immunosuppression. Transplant Proc 23:2152-2156
17. Newton C, Gebhardt B, Kaufman HE (1988) Topically applied cyclosporine in azone prolongs corneal allograft survival. Invest Ophthalmol Vis Sci 29:208-215
18. Hill JC (1989) The use of cyclosporine in high-risk keratoplasty. Am J Ophthalmol 107:506-510
19. Bouchard CS, Kappil JC, Duffner L (1995) The role of systemic cyclosporine dosing schedule on corneal allograft survival in the rat model. Curr Eye Res 14:421-424
20. Xie L, Shi W, Wang Z, Bei J, Wang S (2001) Prolongation of corneal allograft survival using cyclosporine in a polylactide-co-glycolide polymer. Cornea 20:748-752
21. Xie L, Shi W, Li S, Zeng Q (2002) The use of an implantable cyclosporine A delivery system for preventing corneal allograft rejection in patients with alkali-burned corneas. Ophthalmic Pract 20:302-306
22. Dong X, Shi W, Yuan G, Xie L, Wang S, Lin P (2006) Intravitreal implantation of the biodegradable cyclosporin A drug delivery system for experimental chronic uveitis. Graefes Arch Clin Exp Ophthalmol 244:492-497
23. Feng YG, Jin YZ, Zhang QY, Hao J, Wang GM, Xie SS (2005) CTLA4-Fas ligand gene transfer mediated by adenovirus induce long-time survival of murine cardiac allografts. Transplant Proc 37:2379-2381
24. Jin Y, Qu A, Wang GM, Hao J, Gao X, Xie S (2004) Simultaneous stimulation of Fas-mediated apoptosis and blockade of costimulation prevent autoimmune diabetes in mice induced by multiple low-dose streptozotocin. Gene Ther 11:982-991
25. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ (1995) Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 377:348-351
26. Ehl S, Hoffman-Rohrer U, Nagata S, Hengartner H, Zinkernagel R (1996) Different susceptibility of cytotoxic T cells to CD95(Fas/APO-1) ligand-mediated cell death after activation in vitro versus in vivo. J Immunol 156:2357-2360
27. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA (1995) Fas Ligand-induced apoptosis as a mechanism of immune privilege. Science 270:1189-1192
28. Lee RS, Rusche JR, Maloney ME, Sachs DH, Sayegh MH, Madsen JC (2001) CTLA4Ig-induced linked regulation of allogeneic T cell responses. J Immunol 166:1572-1582
29. Stuart PM, Yin X, Plambeck S, Pan F, Ferguson TA (2005) The role of Fas ligand as an effector molecule in corneal graft rejection. Eur J Immunol 35:2591-2597
30. Wells AD, Li XC, Li Y, Walsh MC, Zheng XX, Wu Z, Nunez G, Tang A, Sayegh M, Hancock WW, Strom TB, Turka LA (1999) Requirement for T cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med 5:1303-1307
31. Li XC, Strom TB, Turka LA, Wells AD (2001) T cell death and transplantation tolerance. Immunity 14:407-416
32. Shi W, Xie L (2004) CTLA4-Ig prevents corneal allograft rejection in mice. Chin J Ophthalmol 40:696-700